查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1969321

细胞内假体市场：依产品类型、材质、最终用户、应用和分销管道划分－2026-2032年全球预测

Endoprosthesis Market by Product Type, Material, End User, Application, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 186 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，体内假体市场价值将达到 155.9 亿美元，到 2026 年将成长至 167.5 亿美元，到 2032 年将达到 263.9 亿美元，复合年增长率为 7.80%。

主要市场统计数据
基准年 2025 155.9亿美元
预计年份：2026年 167.5亿美元
预测年份 2032 263.9亿美元
复合年增长率 (%) 7.80%

简洁而有策略的介绍全面概括了人工替代物相关人员假体决策的因素，例如临床创新、对监管的日益重视以及医疗服务的变化。

内臟人工替代物领域的特点是技术快速创新、临床路径不断转变，以及医疗服务提供者、保险公司和患者之间日益复杂的互动。植入材料、製造技术和手术全期通讯协定的进步正在重新定义人们对假体耐用性、生物相容性和功能效果的期望。同时，门诊模式和综合支付方案的试验正在改变施行地点，迫使製造商和医疗系统重新思考供应链、库存和培训投资。

材料科学的突破、数位手术的整合以及基于价值的医疗模式如何重塑体内假体领域的竞争格局和临床应用。

植入式假体领域正经历一场变革，其驱动力来自于材料科学的突破、数位化手术的整合以及医疗服务模式的演变。钛合金、先进聚合物和陶瓷涂层正在提升植入的骨整合性和耐磨性，改变外科医师的选择偏好和产品研发重点。同时，积层製造和精密加工技术能够实现更复杂的形状和患者个性化设计，使企业能够提供差异化的价值提案，以应对诸如解剖结构问题和重新置换风险等独特挑战。

本研究评估了关税制度变化对人工联合供应链的韧性、区域製造策略和采购经济的累积影响。

美国近期推出的关税措施为医疗设备製造商和医疗保健系统的全球供应链规划和筹资策略带来了新的变数。进口零件和成品面临的关税压力，凸显了在地采购、近岸外包和多元化供应商网路对于降低成本波动的重要性。为此，製造商正在重新评估其生产地点，将特定业务转移到更靠近关键终端市场的地方，并加快对区域製造能力的投资，以维持获利能力和交货可靠性。

透过基于深度细分的洞察，将产品类型、最终用户趋势、临床应用、材料和分销管道连结起来，从而确定策略投资领域的优先顺序。

细分市场分析揭示了临床需求、采购行为和产品创新之间的交集，从而为每个细分市场创造了差异化的机会。依产品类型划分，市场可分为牙科（固定式和可拆卸式）、髋关节（部分置换、重新置换和全置换）、膝关节（首次置换和重新置换）、肩关节（部分置换、反向置换和全置换）以及脊椎（颈椎、腰椎和胸椎）市场。不同解剖部位的生命週期和耐用性要求决定了独特的研发重点、监管合规路径和外科培训计划，进而影响产品蓝图和商业性策略。

美洲、欧洲、中东和非洲以及亚太地区的区域市场动态是决定人工关节的监管、报销和引入途径的关键因素。

区域趋势对监管环境、报销机制和技术采纳曲线有显着影响，进而塑造人工关节解决方案的研发和商业化进程。在美洲，完善的报销机制和广泛的医院网络促进了关节重建和脊椎解决方案领域创新技术的快速应用。同时，支付方的严格审查和成本控制压力要求製造商在整个设备生命週期中展现其价值。该地区的竞争格局有利于采用整合服务模式、提供全面的支付方案以及提供证据支持合约谈判。

竞争考察和企业策略洞察突显了产品创新、商业化模式和供应链韧性如何在人工关节领域创造可持续的竞争优势。

来自主要企业的洞察表明，竞争格局中，差异化源于临床证据、一体化服务交付和生产灵活性的综合运用。领先的医疗设备製造商正透过有针对性的收购、与数位医疗供应商建立策略合作伙伴关係以及投资于旨在减少磨损和改善患者疗效的新一代材料来扩展其产品组合。中型创新企业则专注于特定解剖部位、降低重新置换率的技术以及加速临床应用的外科医生培训项目，从而开拓细分市场。

为製造商和医疗保健系统合作伙伴提供切实可行的策略建议，以整合临床证据、製造灵活性和商业模式，从而建立可持续的竞争优势。

寻求巩固市场地位的产业领导者应采取切实可行的措施，兼顾临床价值与商业性可行性。优先投资于已确认能降低再次手术率并改善长期功能的材料和製造工艺，并将这些技术进步与临床证据生成计划相结合，包括参与註册研究和进行真实世界临床结果研究。这些措施将有助于与支付方和医疗系统采购人员进行沟通，并在竞争性合约谈判中建立具有竞争力的价值提案。

严谨的混合调查方法，支持实用见解：结合专家访谈、监管和临床证据的整合以及供应链分析。

本分析的调查方法结合了定性和定量方法，以确保获得全面且可重复的见解。研究首先对骨科医生、牙医、医院采购经理、门诊手术中心管理人员和医疗设备公司高管进行结构化访谈，以此作为主要资讯来源，直接收集他们对临床需求、产品应用驱动因素和购买行为的看法。此外，研究还系统地回顾了监管指导文件、临床试验註册资讯和医疗设备安全讯息，从而更好地理解上市后监测中证据的预期和趋势。

简明扼要的结论是，将临床创新、供应链韧性和综合解决方案策略作为体内假体领域长期成功的基础。

总之，植入物产业正处于一个转折点，其发展受到材料创新、数位整合以及不断演变的医疗服务体系的共同影响。那些将产品开发与可验证的临床结果相结合，并采用灵活的生产和商业模式的製造商，将更有能力应对关税压力和不同的区域趋势。持续朝着以解决方案为导向的交付模式转变，将植入与软体、培训和结果分析相结合，将有利于那些能够为外科医生和医疗系统采购方提供端到端价值的公司。

目录

第一章：序言

第二章：调查方法

  • 调查设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查的前提
  • 研究限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 市场进入策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会映射
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章：细胞内假体市场：依产品类型划分

  • 牙科
    • 固定的
    • 可拆卸的
  • 髋关节
    • 部分替换
    • 重新置换
    • 总合的
  • 膝盖
    • 第一替换
    • 重新置换
  • 肩关节
    • 半球
    • 撤销
    • 总合的
  • 脊椎
    • 颈椎
    • 腰椎
    • 胸椎

第九章：细胞内假体市场：依材料分类

  • 陶瓷
  • 钴铬合金
    • 多孔
    • 固体的
  • 聚合物
  • 钛
  • 超高分子量聚乙烯

第十章：细胞内假体市场：依最终用户划分

  • 门诊手术中心
    • 独立的
    • 医院所有
  • 医院
    • 私人的
    • 民众
  • 整形外科诊所
    • 链
    • 独立

第十一章：细胞内假体市场：依应用领域划分

  • 心血管系统
    • 接枝
    • 心臟瓣膜
    • 血管支架
  • 牙科
    • 桥
    • 植入
  • 神经
    • 夹子
    • 分流
  • 整形外科
    • 关节重建手术
    • 脊椎融合手术
    • 创伤

第十二章：细胞内假体市场：依通路划分

  • 直销
  • 经销商
  • 在线的

第十三章：细胞内假体市场：依地区划分

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十四章：细胞内假体市场：依组别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十五章：细胞内假体市场：依国家划分

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十六章：美国细胞内假体市场

第十七章：中国细胞内假体市场

第十八章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • ConforMIS, Inc.
  • DePuy Synthes, Inc.
  • DJO Global, Inc.
  • Exactech, Inc.
  • Globus Medical
  • LimaCorporate SpA
  • Medacta International SA
  • Medtronic plc
  • MicroPort Scientific Corporation
  • Smith & Nephew plc
  • Stryker Corporation
  • Zimmer Biomet Holdings, Inc.
Product Code: MRR-535C6291883E

The Endoprosthesis Market was valued at USD 15.59 billion in 2025 and is projected to grow to USD 16.75 billion in 2026, with a CAGR of 7.80%, reaching USD 26.39 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 15.59 billion
Estimated Year [2026] USD 16.75 billion
Forecast Year [2032] USD 26.39 billion
CAGR (%) 7.80%

A concise and strategic introduction that frames clinical innovation, regulatory emphasis, and care delivery shifts transforming endoprosthesis decisions for stakeholders

The endoprosthesis landscape is characterized by rapid technological innovation, shifting clinical pathways, and an increasingly complex interplay between providers, payers, and patients. Advancements in implant materials, manufacturing techniques, and perioperative protocols are redefining expectations for longevity, biocompatibility, and functional outcomes. At the same time, outpatient care models and bundled payment experiments are altering where and how procedures are delivered, prompting manufacturers and health systems to reassess supply chain, inventory, and training investments.

Clinicians are adopting more personalized approaches to implant selection, informed by improvements in imaging, planning software, and patient-specific instrumentation. These clinical drivers are complemented by regulatory authorities emphasizing real-world evidence and post-market surveillance, which places a premium on longitudinal data collection and traceability. As a result, market participants must navigate a dynamic environment that rewards integration of clinical insight, robust data capture, and agile commercialization strategies.

Transitioning from traditional prosthesis models toward implants that prioritize durability and modularity, stakeholders increasingly collaborate across specialty areas to address comorbidities and complex anatomies. This introduction sets the stage for a deeper analysis of the transformative shifts shaping the sector and the actionable implications for manufacturers, health systems, and investors seeking to align capabilities with emerging clinical and commercial realities.

How material science breakthroughs, digital surgical integration, and value-based care models are reshaping competitive dynamics and clinical adoption in endoprosthesis

The endoprosthesis sector is undergoing transformative shifts driven by material science breakthroughs, digital surgery integration, and evolving care delivery models. Titanium alloys, advanced polymers, and ceramic coatings are improving implant osseointegration and wear resistance, which in turn reshapes surgeon preferences and product development priorities. Concurrently, additive manufacturing and precision machining enable more complex geometries and patient-specific designs, allowing companies to offer differentiated value propositions that address unique anatomical challenges and revision risks.

Digital tools-from preoperative planning platforms to intraoperative navigation and robotics-are increasingly embedded in procedural workflows. These technologies enhance reproducibility and may shorten learning curves, encouraging adoption in high-volume centers and expanding capability in ambulatory surgical centers. Alongside clinical innovations, reimbursement models and value-based contracting are accelerating the demand for demonstrable outcomes and cost-effectiveness. Payers and health system procurement teams now require robust clinical evidence and lifecycle management strategies that reduce long-term complications and readmissions.

Market participants must adapt their commercial models by offering integrated solutions that combine implants with services such as training, data analytics, and warranty programs. Strategic partnerships between device companies, software firms, and service providers are becoming more common, reflecting a shift from product-centric to solution-oriented offerings. These cumulative shifts are redefining competitive dynamics, emphasizing interoperability, evidence generation, and post-market support as key differentiators.

Assessing the cumulative implications of shifting tariff regimes on supply chain resilience, regional manufacturing strategies, and procurement economics for endoprosthesis

Recent tariff actions in the United States have introduced new variables into global supply chain planning and procurement strategies for medical device companies and health systems. Tariff pressures on imported components and finished devices increase the importance of local sourcing, nearshoring, and diversified supplier networks to mitigate cost volatility. In response, manufacturers are re-evaluating production footprints, shifting certain operations closer to key end markets, and accelerating investments in regional manufacturing capabilities to preserve margin and delivery reliability.

Healthcare providers and group purchasing organizations are reassessing sourcing policies and contract negotiations to reflect higher landed costs and potential lead-time variability. These commercial adjustments encourage more rigorous total-cost-of-ownership analyses that incorporate duties, logistics, and inventory carrying costs. Simultaneously, regulatory compliance and documentation requirements become more salient as firms navigate customs processes and classification challenges that can affect tariff exposure.

The cumulative impact extends to innovation timelines as companies balance the economics of custom or patient-specific solutions with tariffs that disproportionately affect small-batch production. Firms with robust global supply chain engineering, flexible manufacturing, and hedging strategies are better positioned to absorb or pass through cost increases while maintaining competitive pricing. Over time, trade dynamics are likely to incentivize vertically integrated models, strategic alliances with regional manufacturers, and increased emphasis on materials and processes that reduce dependency on tariff-exposed inputs.

Deep segmentation-driven insights that link product types, end-user dynamics, clinical applications, materials, and distribution channels to prioritize strategic investment areas

Segmentation insights reveal where clinical demand, procurement behavior, and product innovation intersect to create differentiated opportunities across subsegments. Based on product type, the market encompasses Dental with fixed and removable options, Hip with partial, revision, and total variants, Knee with primary and revision categories, Shoulder with hemi, reverse, and total designs, and Spine across cervical, lumbar, and thoracic applications. Differentiated lifecycle and durability requirements across these anatomical sites dictate unique R&D priorities, regulatory pathways, and surgeon training programs, shaping product roadmaps and commercial approaches.

Based on end user, adoption and purchasing patterns vary across ambulatory surgical centers, hospitals, and orthopedic clinics. Ambulatory surgical centers include both free-standing and hospital-owned facilities, each with distinct throughput, staffing models, and inventory constraints. Hospitals are split between private and public institutions, which differ in procurement processes, contracting timelines, and reimbursement exposure. Orthopedic clinics include chain and independent practices that influence implant preference through referral networks and local surgeon leadership.

Based on application, clinical focus areas include cardiovascular solutions such as grafts, heart valves, and vascular stents; dental applications including bridges and implants; neuro devices like clips and shunts; and orthopedic interventions spanning joint replacement, spinal fusion, and trauma. These application domains exhibit varying regulatory scrutiny and evidence expectations that impact time-to-market and post-market commitments. Based on material, implants utilize ceramics, cobalt-chrome in porous and solid forms, polymers, titanium, and UHMWPE, with material selection influencing wear characteristics, revision risk, and cost structure. Based on distribution channel, companies deploy direct sales, distributors, and online channels, each demanding tailored commercial operations, inventory strategies, and clinician support models. Understanding these segments in combination enables companies to prioritize investments where clinical need, reimbursement stability, and adoption velocity align most favorably.

Regional market dynamics across the Americas, Europe Middle East & Africa, and Asia Pacific that determine regulatory, reimbursement, and adoption pathways for endoprosthesis

Regional dynamics exert meaningful influence on regulatory landscapes, reimbursement frameworks, and technology adoption curves, shaping how endoprosthesis solutions are developed and commercialized. In the Americas, established reimbursement pathways and an extensive hospital network support rapid uptake of innovations in joint replacement and spinal solutions, while payer scrutiny and cost containment pressures force manufacturers to demonstrate value across device lifecycles. The competitive environment in this region favors integrated service models, bundled payment readiness, and evidence generation to support contracting discussions.

In Europe, the Middle East & Africa region, regulatory harmonization efforts coexist with heterogeneous reimbursement systems, creating both opportunities and complexity for manufacturers. Several high-income European markets prioritize robust post-market surveillance and clinical registries, which raise the bar for evidence but also create a credible pathway to premium positioning for proven technologies. Middle Eastern markets often pursue public-private partnerships and strategic investments in orthopedics, while various African markets present growth potential tied to infrastructure investment and access initiatives.

Asia-Pacific is characterized by a wide spectrum of market maturity, from advanced centers with high adoption of digital surgery and premium implants to emerging markets where cost-conscious products and scalable distribution models are critical. Local manufacturing capabilities, government procurement policies, and demographic trends such as aging populations and rising elective procedure volumes shape regional priorities. Across all regions, successful market entrants respect local clinical practice patterns, invest in registrar and outcomes data where required, and align commercial strategies with regional procurement norms to accelerate acceptance and sustainable growth.

Competitive and corporate strategic insights highlighting how product innovation, commercialization models, and supply chain resilience create sustained advantage in endoprosthesis

Key company insights point to a competitive landscape where differentiation stems from a combination of clinical evidence, integrated service offerings, and manufacturing agility. Leading medical device firms are expanding portfolios through targeted acquisitions, strategic collaborations with digital health vendors, and investments in next-generation materials to reduce wear and improve patient outcomes. Mid-sized innovators are carving niches by focusing on specific anatomical sites, revision reduction technologies, and surgeon-oriented training programs that accelerate clinical adoption.

Smaller, specialized players often succeed by bringing disruptive designs to market rapidly and partnering with larger distributors or platform companies to scale. These companies typically emphasize rapid clinical feedback loops, streamlined regulatory submissions in key jurisdictions, and flexible pricing models tailored to ambulatory surgical centers and independent clinics. Across the ecosystem, collaboration between device manufacturers and software providers is increasingly common, enabling bundled solutions that combine implants with planning, navigation, and outcomes tracking.

Competitive positioning also depends on supply chain resilience and the ability to localize production when tariffs or logistics disruptions threaten continuity. Companies that provide comprehensive post-market support, long-term warranties, and demonstrable outcomes data tend to secure preferred-provider status with health systems. Ultimately, sustainable advantage accrues to organizations that integrate clinical innovation with robust commercialization capabilities and a clear line of sight from surgeon needs to product development priorities.

Actionable strategic recommendations for manufacturers and health system partners to align clinical evidence, manufacturing agility, and commercial models for durable competitive advantage

Industry leaders seeking to strengthen market position should pursue a set of actionable moves that align clinical value with commercial viability. Prioritize investments in materials and manufacturing processes that demonstrably reduce revision rates and improve long-term function, and pair these technical advances with clinical evidence generation plans that include registry participation and real-world outcomes studies. These actions will support discussions with payers and health system procurement leaders and build a defensible value proposition in competitive contract negotiations.

Adopt integrated solution strategies that bundle implants with digital planning tools, surgeon training, and post-operative analytics to differentiate offerings and create recurring revenue streams. Expand regional manufacturing footprint strategically to mitigate tariff exposure and reduce lead-time risk, while maintaining flexibility for small-batch or patient-specific production. Strengthen partnerships with ambulatory surgical centers and chain orthopedic practices by developing tailored commercial models that address their unique inventory, staffing, and throughput challenges.

Finally, accelerate internal capabilities in market access and health economics to communicate the full lifetime benefits of implant selection, and invest in cross-functional teams that translate clinical performance into procurement-ready value propositions. By implementing these measures, companies can improve adoption velocity, reduce commercial friction, and align long-term product development with evolving care delivery and reimbursement realities.

A rigorous mixed-methods research methodology combining expert interviews, regulatory and clinical evidence synthesis, and supply chain analysis to underpin actionable insights

The research methodology underpinning this analysis combines qualitative and quantitative approaches to ensure comprehensive, reproducible insights. Primary inputs include structured interviews with orthopedic and dental surgeons, hospital procurement leaders, ambulatory surgical center administrators, and device executives to capture firsthand perspectives on clinical needs, adoption drivers, and purchasing behavior. These interviews are complemented by a systematic review of regulatory guidance documents, clinical trial registries, and device safety communications to contextualize evidence expectations and post-market monitoring trends.

Secondary research integrates peer-reviewed literature, specialty society guidelines, and publicly available registry reports to triangulate clinical outcomes and device performance characteristics. Supply chain and trade data inform assessments of tariff exposure and regional manufacturing implications, while technology adoption studies shed light on the operational impact of digital surgical tools. Wherever possible, triangulation of multiple data sources is used to validate assertions and reduce single-source bias.

Analytical frameworks employed include segmentation mapping, value chain analysis, and scenario planning to explore the implications of tariff shifts, regulatory changes, and material innovations. Findings are synthesized into actionable insights with clear linkage between data sources and strategic recommendations, enabling stakeholders to apply the analysis to product development, market entry, and sourcing decisions with confidence.

A concise conclusion synthesizing clinical innovation, supply chain resilience, and integrated solution strategies as the pillars of long-term success in endoprosthesis

In conclusion, the endoprosthesis sector stands at an inflection point shaped by materials innovation, digital integration, and evolving care-delivery economics. Manufacturers that align product development with demonstrable clinical outcomes and that adopt flexible manufacturing and commercial models will be better positioned to navigate tariff pressures and varied regional dynamics. The ongoing shift toward solution-oriented offerings that bundle implants with software, training, and outcomes analytics will favor companies capable of delivering end-to-end value to surgeons and health system purchasers.

Successful market participants will emphasize robust evidence generation, engagement with registries, and transparent post-market surveillance to build trust and justify premium positioning. Regional strategies must respect local procurement norms and regulatory expectations while leveraging nearshoring and strategic partnerships to protect margins and ensure supply continuity. By acting decisively on these themes-clinical differentiation, supply chain resilience, and integrated solutions-stakeholders can capture sustainable opportunities in a market that rewards long-term performance and demonstrable patient benefit.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Endoprosthesis Market, by Product Type

  • 8.1. Dental
    • 8.1.1. Fixed
    • 8.1.2. Removable
  • 8.2. Hip
    • 8.2.1. Partial
    • 8.2.2. Revision
    • 8.2.3. Total
  • 8.3. Knee
    • 8.3.1. Primary
    • 8.3.2. Revision
  • 8.4. Shoulder
    • 8.4.1. Hemi
    • 8.4.2. Reverse
    • 8.4.3. Total
  • 8.5. Spine
    • 8.5.1. Cervical
    • 8.5.2. Lumbar
    • 8.5.3. Thoracic

9. Endoprosthesis Market, by Material

  • 9.1. Ceramics
  • 9.2. Cobalt-Chrome
    • 9.2.1. Porous
    • 9.2.2. Solid
  • 9.3. Polymers
  • 9.4. Titanium
  • 9.5. Uhmwpe

10. Endoprosthesis Market, by End User

  • 10.1. Ambulatory Surgical Centers
    • 10.1.1. Free-Standing
    • 10.1.2. Hospital-Owned
  • 10.2. Hospitals
    • 10.2.1. Private
    • 10.2.2. Public
  • 10.3. Orthopedic Clinics
    • 10.3.1. Chain
    • 10.3.2. Independent

11. Endoprosthesis Market, by Application

  • 11.1. Cardiovascular
    • 11.1.1. Grafts
    • 11.1.2. Heart Valves
    • 11.1.3. Vascular Stents
  • 11.2. Dental
    • 11.2.1. Bridges
    • 11.2.2. Implants
  • 11.3. Neuro
    • 11.3.1. Clips
    • 11.3.2. Shunts
  • 11.4. Orthopedic
    • 11.4.1. Joint Replacement
    • 11.4.2. Spinal Fusion
    • 11.4.3. Trauma

12. Endoprosthesis Market, by Distribution Channel

  • 12.1. Direct Sales
  • 12.2. Distributors
  • 12.3. Online

13. Endoprosthesis Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Endoprosthesis Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Endoprosthesis Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Endoprosthesis Market

17. China Endoprosthesis Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. ConforMIS, Inc.
  • 18.6. DePuy Synthes, Inc.
  • 18.7. DJO Global, Inc.
  • 18.8. Exactech, Inc.
  • 18.9. Globus Medical
  • 18.10. LimaCorporate S.p.A.
  • 18.11. Medacta International S.A.
  • 18.12. Medtronic plc
  • 18.13. MicroPort Scientific Corporation
  • 18.14. Smith & Nephew plc
  • 18.15. Stryker Corporation
  • 18.16. Zimmer Biomet Holdings, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL ENDOPROSTHESIS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL ENDOPROSTHESIS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL ENDOPROSTHESIS MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL ENDOPROSTHESIS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL ENDOPROSTHESIS MARKET SIZE, BY MATERIAL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL ENDOPROSTHESIS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL ENDOPROSTHESIS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL ENDOPROSTHESIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL ENDOPROSTHESIS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL ENDOPROSTHESIS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL ENDOPROSTHESIS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES ENDOPROSTHESIS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA ENDOPROSTHESIS MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL ENDOPROSTHESIS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL ENDOPROSTHESIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL ENDOPROSTHESIS MARKET SIZE, BY DENTAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL ENDOPROSTHESIS MARKET SIZE, BY DENTAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL ENDOPROSTHESIS MARKET SIZE, BY DENTAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL ENDOPROSTHESIS MARKET SIZE, BY DENTAL, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL ENDOPROSTHESIS MARKET SIZE, BY FIXED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL ENDOPROSTHESIS MARKET SIZE, BY FIXED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL ENDOPROSTHESIS MARKET SIZE, BY FIXED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL ENDOPROSTHESIS MARKET SIZE, BY REMOVABLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL ENDOPROSTHESIS MARKET SIZE, BY REMOVABLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL ENDOPROSTHESIS MARKET SIZE, BY REMOVABLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL ENDOPROSTHESIS MARKET SIZE, BY HIP, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL ENDOPROSTHESIS MARKET SIZE, BY HIP, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL ENDOPROSTHESIS MARKET SIZE, BY HIP, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL ENDOPROSTHESIS MARKET SIZE, BY HIP, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL ENDOPROSTHESIS MARKET SIZE, BY PARTIAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL ENDOPROSTHESIS MARKET SIZE, BY PARTIAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL ENDOPROSTHESIS MARKET SIZE, BY PARTIAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL ENDOPROSTHESIS MARKET SIZE, BY REVISION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL ENDOPROSTHESIS MARKET SIZE, BY REVISION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL ENDOPROSTHESIS MARKET SIZE, BY REVISION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL ENDOPROSTHESIS MARKET SIZE, BY TOTAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL ENDOPROSTHESIS MARKET SIZE, BY TOTAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL ENDOPROSTHESIS MARKET SIZE, BY TOTAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL ENDOPROSTHESIS MARKET SIZE, BY KNEE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL ENDOPROSTHESIS MARKET SIZE, BY KNEE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL ENDOPROSTHESIS MARKET SIZE, BY KNEE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL ENDOPROSTHESIS MARKET SIZE, BY KNEE, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL ENDOPROSTHESIS MARKET SIZE, BY PRIMARY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL ENDOPROSTHESIS MARKET SIZE, BY PRIMARY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL ENDOPROSTHESIS MARKET SIZE, BY PRIMARY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL ENDOPROSTHESIS MARKET SIZE, BY REVISION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL ENDOPROSTHESIS MARKET SIZE, BY REVISION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL ENDOPROSTHESIS MARKET SIZE, BY REVISION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL ENDOPROSTHESIS MARKET SIZE, BY SHOULDER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL ENDOPROSTHESIS MARKET SIZE, BY SHOULDER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL ENDOPROSTHESIS MARKET SIZE, BY SHOULDER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL ENDOPROSTHESIS MARKET SIZE, BY SHOULDER, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL ENDOPROSTHESIS MARKET SIZE, BY HEMI, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL ENDOPROSTHESIS MARKET SIZE, BY HEMI, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL ENDOPROSTHESIS MARKET SIZE, BY HEMI, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL ENDOPROSTHESIS MARKET SIZE, BY REVERSE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL ENDOPROSTHESIS MARKET SIZE, BY REVERSE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL ENDOPROSTHESIS MARKET SIZE, BY REVERSE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL ENDOPROSTHESIS MARKET SIZE, BY TOTAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL ENDOPROSTHESIS MARKET SIZE, BY TOTAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL ENDOPROSTHESIS MARKET SIZE, BY TOTAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL ENDOPROSTHESIS MARKET SIZE, BY SPINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL ENDOPROSTHESIS MARKET SIZE, BY SPINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL ENDOPROSTHESIS MARKET SIZE, BY SPINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL ENDOPROSTHESIS MARKET SIZE, BY SPINE, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL ENDOPROSTHESIS MARKET SIZE, BY CERVICAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL ENDOPROSTHESIS MARKET SIZE, BY CERVICAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL ENDOPROSTHESIS MARKET SIZE, BY CERVICAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL ENDOPROSTHESIS MARKET SIZE, BY LUMBAR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL ENDOPROSTHESIS MARKET SIZE, BY LUMBAR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL ENDOPROSTHESIS MARKET SIZE, BY LUMBAR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL ENDOPROSTHESIS MARKET SIZE, BY THORACIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL ENDOPROSTHESIS MARKET SIZE, BY THORACIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL ENDOPROSTHESIS MARKET SIZE, BY THORACIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL ENDOPROSTHESIS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL ENDOPROSTHESIS MARKET SIZE, BY CERAMICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL ENDOPROSTHESIS MARKET SIZE, BY CERAMICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL ENDOPROSTHESIS MARKET SIZE, BY CERAMICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL ENDOPROSTHESIS MARKET SIZE, BY COBALT-CHROME, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL ENDOPROSTHESIS MARKET SIZE, BY COBALT-CHROME, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL ENDOPROSTHESIS MARKET SIZE, BY COBALT-CHROME, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL ENDOPROSTHESIS MARKET SIZE, BY COBALT-CHROME, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL ENDOPROSTHESIS MARKET SIZE, BY POROUS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL ENDOPROSTHESIS MARKET SIZE, BY POROUS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL ENDOPROSTHESIS MARKET SIZE, BY POROUS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL ENDOPROSTHESIS MARKET SIZE, BY SOLID, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL ENDOPROSTHESIS MARKET SIZE, BY SOLID, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL ENDOPROSTHESIS MARKET SIZE, BY SOLID, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL ENDOPROSTHESIS MARKET SIZE, BY POLYMERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL ENDOPROSTHESIS MARKET SIZE, BY POLYMERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL ENDOPROSTHESIS MARKET SIZE, BY POLYMERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL ENDOPROSTHESIS MARKET SIZE, BY TITANIUM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL ENDOPROSTHESIS MARKET SIZE, BY TITANIUM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL ENDOPROSTHESIS MARKET SIZE, BY TITANIUM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL ENDOPROSTHESIS MARKET SIZE, BY UHMWPE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL ENDOPROSTHESIS MARKET SIZE, BY UHMWPE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL ENDOPROSTHESIS MARKET SIZE, BY UHMWPE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL ENDOPROSTHESIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL ENDOPROSTHESIS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL ENDOPROSTHESIS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL ENDOPROSTHESIS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL ENDOPROSTHESIS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL ENDOPROSTHESIS MARKET SIZE, BY FREE-STANDING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL ENDOPROSTHESIS MARKET SIZE, BY FREE-STANDING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL ENDOPROSTHESIS MARKET SIZE, BY FREE-STANDING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL ENDOPROSTHESIS MARKET SIZE, BY HOSPITAL-OWNED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL ENDOPROSTHESIS MARKET SIZE, BY HOSPITAL-OWNED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL ENDOPROSTHESIS MARKET SIZE, BY HOSPITAL-OWNED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL ENDOPROSTHESIS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL ENDOPROSTHESIS MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL ENDOPROSTHESIS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL ENDOPROSTHESIS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL ENDOPROSTHESIS MARKET SIZE, BY PRIVATE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL ENDOPROSTHESIS MARKET SIZE, BY PRIVATE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL ENDOPROSTHESIS MARKET SIZE, BY PRIVATE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL ENDOPROSTHESIS MARKET SIZE, BY PUBLIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL ENDOPROSTHESIS MARKET SIZE, BY PUBLIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL ENDOPROSTHESIS MARKET SIZE, BY PUBLIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL ENDOPROSTHESIS MARKET SIZE, BY ORTHOPEDIC CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL ENDOPROSTHESIS MARKET SIZE, BY ORTHOPEDIC CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL ENDOPROSTHESIS MARKET SIZE, BY ORTHOPEDIC CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL ENDOPROSTHESIS MARKET SIZE, BY ORTHOPEDIC CLINICS, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL ENDOPROSTHESIS MARKET SIZE, BY CHAIN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL ENDOPROSTHESIS MARKET SIZE, BY CHAIN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL ENDOPROSTHESIS MARKET SIZE, BY CHAIN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL ENDOPROSTHESIS MARKET SIZE, BY INDEPENDENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL ENDOPROSTHESIS MARKET SIZE, BY INDEPENDENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL ENDOPROSTHESIS MARKET SIZE, BY INDEPENDENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL ENDOPROSTHESIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL ENDOPROSTHESIS MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL ENDOPROSTHESIS MARKET SIZE, BY CARDIOVASCULAR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL ENDOPROSTHESIS MARKET SIZE, BY CARDIOVASCULAR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL ENDOPROSTHESIS MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL ENDOPROSTHESIS MARKET SIZE, BY GRAFTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL ENDOPROSTHESIS MARKET SIZE, BY GRAFTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL ENDOPROSTHESIS MARKET SIZE, BY GRAFTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 124. GLOBAL ENDOPROSTHESIS MARKET SIZE, BY HEART VALVES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL ENDOPROSTHESIS MARKET SIZE, BY HEART VALVES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 126. GLOBAL ENDOPROSTHESIS MARKET SIZE, BY HEART VALVES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 127. GLOBAL ENDOPROSTHESIS MARKET SIZE, BY VASCULAR STENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 128. GLOBAL ENDOPROSTHESIS MARKET SIZE, BY VASCULAR STENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 129. GLOBAL ENDOPROSTHESIS MARKET SIZE, BY VASCULAR STENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 130. GLOBAL ENDOPROSTHESIS MARKET SIZE, BY DENTAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 131. GLOBAL ENDOPROSTHESIS MARKET SIZE, BY DENTAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 132. GLOBAL ENDOPROSTHESIS MARKET SIZE, BY DENTAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 133. GLOBAL ENDOPROSTHESIS MARKET SIZE, BY DENTAL, 2018-2032 (USD MILLION)
  • TABLE 134. GLOBAL ENDOPROSTHESIS MARKET SIZE, BY BRIDGES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 135. GLOBAL ENDOPROSTHESIS MARKET SIZE, BY BRIDGES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 136. GLOBAL ENDOPROSTHESIS MARKET SIZE, BY BRIDGES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 137. GLOBAL ENDOPROSTHESIS MARKET SIZE, BY IMPLANTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 138. GLOBAL ENDOPROSTHESIS MARKET SIZE, BY IMPLANTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 139. GLOBAL ENDOPROSTHESIS MARKET SIZE, BY IMPLANTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 140. GLOBAL ENDOPROSTHESIS MARKET SIZE, BY NEURO, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 141. GLOBAL ENDOPROSTHESIS MARKET SIZE, BY NEURO, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 142. GLOBAL ENDOPROSTHESIS MARKET SIZE, BY NEURO, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 143. GLOBAL ENDOPROSTHESIS MARKET SIZE, BY NEURO, 2018-2032 (USD MILLION)
  • TABLE 144. GLOBAL ENDOPROSTHESIS MARKET SIZE, BY CLIPS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 145. GLOBAL ENDOPROSTHESIS MARKET SIZE, BY CLIPS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 146. GLOBAL ENDOPROSTHESIS MARKET SIZE, BY CLIPS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 147. GLOBAL ENDOPROSTHESIS MARKET SIZE, BY SHUNTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 148. GLOBAL ENDOPROSTHESIS MARKET SIZE, BY SHUNTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 149. GLOBAL ENDOPROSTHESIS MARKET SIZE, BY SHUNTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 150. GLOBAL ENDOPROSTHESIS MARKET SIZE, BY ORTHOPEDIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 151. GLOBAL ENDOPROSTHESIS MARKET SIZE, BY ORTHOPEDIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 152. GLOBAL ENDOPROSTHESIS MARKET SIZE, BY ORTHOPEDIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 153. GLOBAL ENDOPROSTHESIS MARKET SIZE, BY ORTHOPEDIC, 2018-2032 (USD MILLION)
  • TABLE 154. GLOBAL ENDOPROSTHESIS MARKET SIZE, BY JOINT REPLACEMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 155. GLOBAL ENDOPROSTHESIS MARKET SIZE, BY JOINT REPLACEMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 156. GLOBAL ENDOPROSTHESIS MARKET SIZE, BY JOINT REPLACEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 157. GLOBAL ENDOPROSTHESIS MARKET SIZE, BY SPINAL FUSION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 158. GLOBAL ENDOPROSTHESIS MARKET SIZE, BY SPINAL FUSION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 159. GLOBAL ENDOPROSTHESIS MARKET SIZE, BY SPINAL FUSION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 160. GLOBAL ENDOPROSTHESIS MARKET SIZE, BY TRAUMA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 161. GLOBAL ENDOPROSTHESIS MARKET SIZE, BY TRAUMA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 162. GLOBAL ENDOPROSTHESIS MARKET SIZE, BY TRAUMA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 163. GLOBAL ENDOPROSTHESIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 164. GLOBAL ENDOPROSTHESIS MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 165. GLOBAL ENDOPROSTHESIS MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 166. GLOBAL ENDOPROSTHESIS MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 167. GLOBAL ENDOPROSTHESIS MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 168. GLOBAL ENDOPROSTHESIS MARKET SIZE, BY DISTRIBUTORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 169. GLOBAL ENDOPROSTHESIS MARKET SIZE, BY DISTRIBUTORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 170. GLOBAL ENDOPROSTHESIS MARKET SIZE, BY ONLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 171. GLOBAL ENDOPROSTHESIS MARKET SIZE, BY ONLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 172. GLOBAL ENDOPROSTHESIS MARKET SIZE, BY ONLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 173. GLOBAL ENDOPROSTHESIS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 174. AMERICAS ENDOPROSTHESIS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 175. AMERICAS ENDOPROSTHESIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 176. AMERICAS ENDOPROSTHESIS MARKET SIZE, BY DENTAL, 2018-2032 (USD MILLION)
  • TABLE 177. AMERICAS ENDOPROSTHESIS MARKET SIZE, BY HIP, 2018-2032 (USD MILLION)
  • TABLE 178. AMERICAS ENDOPROSTHESIS MARKET SIZE, BY KNEE, 2018-2032 (USD MILLION)
  • TABLE 179. AMERICAS ENDOPROSTHESIS MARKET SIZE, BY SHOULDER, 2018-2032 (USD MILLION)
  • TABLE 180. AMERICAS ENDOPROSTHESIS MARKET SIZE, BY SPINE, 2018-2032 (USD MILLION)
  • TABLE 181. AMERICAS ENDOPROSTHESIS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 182. AMERICAS ENDOPROSTHESIS MARKET SIZE, BY COBALT-CHROME, 2018-2032 (USD MILLION)
  • TABLE 183. AMERICAS ENDOPROSTHESIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 184. AMERICAS ENDOPROSTHESIS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 185. AMERICAS ENDOPROSTHESIS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 186. AMERICAS ENDOPROSTHESIS MARKET SIZE, BY ORTHOPEDIC CLINICS, 2018-2032 (USD MILLION)
  • TABLE 187. AMERICAS ENDOPROSTHESIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 188. AMERICAS ENDOPROSTHESIS MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 189. AMERICAS ENDOPROSTHESIS MARKET SIZE, BY DENTAL, 2018-2032 (USD MILLION)
  • TABLE 190. AMERICAS ENDOPROSTHESIS MARKET SIZE, BY NEURO, 2018-2032 (USD MILLION)
  • TABLE 191. AMERICAS ENDOPROSTHESIS MARKET SIZE, BY ORTHOPEDIC, 2018-2032 (USD MILLION)
  • TABLE 192. AMERICAS ENDOPROSTHESIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 193. NORTH AMERICA ENDOPROSTHESIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 194. NORTH AMERICA ENDOPROSTHESIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 195. NORTH AMERICA ENDOPROSTHESIS MARKET SIZE, BY DENTAL, 2018-2032 (USD MILLION)
  • TABLE 196. NORTH AMERICA ENDOPROSTHESIS MARKET SIZE, BY HIP, 2018-2032 (USD MILLION)
  • TABLE 197. NORTH AMERICA ENDOPROSTHESIS MARKET SIZE, BY KNEE, 2018-2032 (USD MILLION)
  • TABLE 198. NORTH AMERICA ENDOPROSTHESIS MARKET SIZE, BY SHOULDER, 2018-2032 (USD MILLION)
  • TABLE 199. NORTH AMERICA ENDOPROSTHESIS MARKET SIZE, BY SPINE, 2018-2032 (USD MILLION)
  • TABLE 200. NORTH AMERICA ENDOPROSTHESIS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 201. NORTH AMERICA ENDOPROSTHESIS MARKET SIZE, BY COBALT-CHROME, 2018-2032 (USD MILLION)
  • TABLE 202. NORTH AMERICA ENDOPROSTHESIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 203. NORTH AMERICA ENDOPROSTHESIS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 204. NORTH AMERICA ENDOPROSTHESIS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 205. NORTH AMERICA ENDOPROSTHESIS MARKET SIZE, BY ORTHOPEDIC CLINICS, 2018-2032 (USD MILLION)
  • TABLE 206. NORTH AMERICA ENDOPROSTHESIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 207. NORTH AMERICA ENDOPROSTHESIS MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 208. NORTH AMERICA ENDOPROSTHESIS MARKET SIZE, BY DENTAL, 2018-2032 (USD MILLION)
  • TABLE 209. NORTH AMERICA ENDOPROSTHESIS MARKET SIZE, BY NEURO, 2018-2032 (USD MILLION)
  • TABLE 210. NORTH AMERICA ENDOPROSTHESIS MARKET SIZE, BY ORTHOPEDIC, 2018-2032 (USD MILLION)
  • TABLE 211. NORTH AMERICA ENDOPROSTHESIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 212. LATIN AMERICA ENDOPROSTHESIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 213. LATIN AMERICA ENDOPROSTHESIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 214. LATIN AMERICA ENDOPROSTHESIS MARKET SIZE, BY DENTAL, 2018-2032 (USD MILLION)
  • TABLE 215. LATIN AMERICA ENDOPROSTHESIS MARKET SIZE, BY HIP, 2018-2032 (USD MILLION)
  • TABLE 216. LATIN AMERICA ENDOPROSTHESIS MARKET SIZE, BY KNEE, 2018-2032 (USD MILLION)
  • TABLE 217. LATIN AMERICA ENDOPROSTHESIS MARKET SIZE, BY SHOULDER, 2018-2032 (USD MILLION)
  • TABLE 218. LATIN AMERICA ENDOPROSTHESIS MARKET SIZE, BY SPINE, 2018-2032 (USD MILLION)
  • TABLE 219. LATIN AMERICA ENDOPROSTHESIS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 220. LATIN AMERICA ENDOPROSTHESIS MARKET SIZE, BY COBALT-CHROME, 2018-2032 (USD MILLION)
  • TABLE 221. LATIN AMERICA ENDOPROSTHESIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 222. LATIN AMERICA ENDOPROSTHESIS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 223. LATIN AMERICA ENDOPROSTHESIS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 224. LATIN AMERICA ENDOPROSTHESIS MARKET SIZE, BY ORTHOPEDIC CLINICS, 2018-2032 (USD MILLION)
  • TABLE 225. LATIN AMERICA ENDOPROSTHESIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 226. LATIN AMERICA ENDOPROSTHESIS MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 227. LATIN AMERICA ENDOPROSTHESIS MARKET SIZE, BY DENTAL, 2018-2032 (USD MILLION)
  • TABLE 228. LATIN AMERICA ENDOPROSTHESIS MARKET SIZE, BY NEURO, 2018-2032 (USD MILLION)
  • TABLE 229. LATIN AMERICA ENDOPROSTHESIS MARKET SIZE, BY ORTHOPEDIC, 2018-2032 (USD MILLION)
  • TABLE 230. LATIN AMERICA ENDOPROSTHESIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 231. EUROPE, MIDDLE EAST & AFRICA ENDOPROSTHESIS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 232. EUROPE, MIDDLE EAST & AFRICA ENDOPROSTHESIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 233. EUROPE, MIDDLE EAST & AFRICA ENDOPROSTHESIS MARKET SIZE, BY DENTAL, 2018-2032 (USD MILLION)
  • TABLE 234. EUROPE, MIDDLE EAST & AFRICA ENDOPROSTHESIS MARKET SIZE, BY HIP, 2018-2032 (USD MILLION)
  • TABLE 235. EUROPE, MIDDLE EAST & AFRICA ENDOPROSTHESIS MARKET SIZE, BY KNEE, 2018-2032 (USD MILLION)
  • TABLE 236. EUROPE, MIDDLE EAST & AFRICA ENDOPROSTHESIS MARKET SIZE, BY SHOULDER, 2018-2032 (USD MILLION)
  • TABLE 237. EUROPE, MIDDLE EAST & AFRICA ENDOPROSTHESIS MARKET SIZE, BY SPINE, 2018-2032 (USD MILLION)
  • TABLE 238. EUROPE, MIDDLE EAST & AFRICA ENDOPROSTHESIS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 239. EUROPE, MIDDLE EAST & AFRICA ENDOPROSTHESIS MARKET SIZE, BY COBALT-CHROME, 2018-2032 (USD MILLION)
  • TABLE 240. EUROPE, MIDDLE EAST & AFRICA ENDOPROSTHESIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 241. EUROPE, MIDDLE EAST & AFRICA ENDOPROSTHESIS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 242. EUROPE, MIDDLE EAST & AFRICA ENDOPROSTHESIS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 243. EUROPE, MIDDLE EAST & AFRICA ENDOPROSTHESIS MARKET SIZE, BY ORTHOPEDIC CLINICS, 2018-2032 (USD MILLION)
  • TABLE 244. EUROPE, MIDDLE EAST & AFRICA ENDOPROSTHESIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 245. EUROPE, MIDDLE EAST & AFRICA ENDOPROSTHESIS MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 246. EUROPE, MIDDLE EAST & AFRICA ENDOPROSTHESIS MARKET SIZE, BY DENTAL, 2018-2032 (USD MILLION)
  • TABLE 247. EUROPE, MIDDLE EAST & AFRICA ENDOPROSTHESIS MARKET SIZE, BY NEURO, 2018-2032 (USD MILLION)
  • TABLE 248. EUROPE, MIDDLE EAST & AFRICA ENDOPROSTHESIS MARKET SIZE, BY ORTHOPEDIC, 2018-2032 (USD MILLION)
  • TABLE 249. EUROPE, MIDDLE EAST & AFRICA ENDOPROSTHESIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 250. EUROPE ENDOPROSTHESIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 251. EUROPE ENDOPROSTHESIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 252. EUROPE ENDOPROSTHESIS MARKET SIZE, BY DENTAL, 2018-2032 (USD MILLION)
  • TABLE 253. EUROPE ENDOPROSTHESIS MARKET SIZE, BY HIP, 2018-2032 (USD MILLION)
  • TABLE 254. EUROPE ENDOPROSTHESIS MARKET SIZE, BY KNEE, 2018-2032 (USD MILLION)
  • TABLE 255. EUROPE ENDOPROSTHESIS MARKET SIZE, BY SHOULDER, 2018-2032 (USD MILLION)
  • TABLE 256. EUROPE ENDOPROSTHESIS MARKET SIZE, BY SPINE, 2018-2032 (USD MILLION)
  • TABLE 257. EUROPE ENDOPROSTHESIS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 258. EUROPE ENDOPROSTHESIS MARKET SIZE, BY COBALT-CHROME, 2018-2032 (USD MILLION)
  • TABLE 259. EUROPE ENDOPROSTHESIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 260. EUROPE ENDOPROSTHESIS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 261. EUROPE ENDOPROSTHESIS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 262. EUROPE ENDOPROSTHESIS MARKET SIZE, BY ORTHOPEDIC CLINICS, 2018-2032 (USD MILLION)
  • TABLE 263. EUROPE ENDOPROSTHESIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 264. EUROPE ENDOPROSTHESIS MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 265. EUROPE ENDOPROSTHESIS MARKET SIZE, BY DENTAL, 2018-2032 (USD MILLION)
  • TABLE 266. EUROPE ENDOPROSTHESIS MARKET SIZE, BY NEURO, 2018-2032 (USD MILLION)
  • TABLE 267. EUROPE ENDOPROSTHESIS MARKET SIZE, BY ORTHOPEDIC, 2018-2032 (USD MILLION)
  • TABLE 268. EUROPE ENDOPROSTHESIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 269. MIDDLE EAST ENDOPROSTHESIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 270. MIDDLE EAST ENDOPROSTHESIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 271. MIDDLE EAST ENDOPROSTHESIS MARKET SIZE, BY DENTAL, 2018-2032 (USD MILLION)
  • TABLE 272. MIDDLE EAST ENDOPROSTHESIS MARKET SIZE, BY HIP, 2018-2032 (USD MILLION)
  • TABLE 273. MIDDLE EAST ENDOPROSTHESIS MARKET SIZE, BY KNEE, 2018-2032 (USD MILLION)
  • TABLE 274. MIDDLE EAST ENDOPROSTHESIS MARKET SIZE, BY SHOULDER, 2018-2032 (USD MILLION)
  • TABLE 275. MIDDLE EAST ENDOPROSTHESIS MARKET SIZE, BY SPINE, 2018-2032 (USD MILLION)
  • TABLE 276. MIDDLE EAST ENDOPROSTHESIS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 277. MIDDLE EAST ENDOPROSTHESIS MARKET SIZE, BY COBALT-CHROME, 2018-2032 (USD MILLION)
  • TABLE 278. MIDDLE EAST ENDOPROSTHESIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 279. MIDDLE EAST ENDOPROSTHESIS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 280. MIDDLE EAST ENDOPROSTHESIS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 281. MIDDLE EAST ENDOPROSTHESIS MARKET SIZE, BY ORTHOPEDIC CLINICS, 2018-2032 (USD MILLION)
  • TABLE 282. MIDDLE EAST ENDOPROSTHESIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 283. MIDDLE EAST ENDOPROSTHESIS MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 284. MIDDLE EAST ENDOPROSTHESIS MARKET SIZE, BY DENTAL, 2018-2032 (USD MILLION)
  • TABLE 285. MIDDLE EAST ENDOPROSTHESIS MARKET SIZE, BY NEURO, 2018-2032 (USD MILLION)
  • TABLE 286. MIDDLE EAST ENDOPROSTHESIS MARKET SIZE, BY ORTHOPEDIC, 2018-2032 (USD MILLION)
  • TABLE 287. MIDDLE EAST ENDOPROSTHESIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 288. AFRICA ENDOPROSTHESIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 289. AFRICA ENDOPROSTHESIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 290. AFRICA ENDOPROSTHESIS MARKET SIZE, BY DENTAL, 2018-2032 (USD MILLION)
  • TABLE 291. AFRICA ENDOPROSTHESIS MARKET SIZE, BY HIP, 2018-2032 (USD MILLION)
  • TABLE 292. AFRICA ENDOPROSTHESIS MARKET SIZE, BY KNEE, 2018-2032 (USD MILLION)
  • TABLE 293. AFRICA ENDOPROSTHESIS MARKET SIZE, BY SHOULDER, 2018-2032 (USD MILLION)
  • TABLE 294. AFRICA ENDOPROSTHESIS MARKET SIZE, BY SPINE, 2018-2032 (USD MILLION)
  • TABLE 295. AFRICA ENDOPROSTHESIS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 296. AFRICA ENDOPROSTHESIS MARKET SIZE, BY COBALT-CHROME, 2018-2032 (USD MILLION)
  • TABLE 297. AFRICA ENDOPROSTHESIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 298. AFRICA ENDOPROSTHESIS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 299. AFRICA ENDOPROSTHESIS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 300. AFRICA ENDOPROSTHESIS MARKET SIZE, BY ORTHOPEDIC CLINICS, 2018-2032 (USD MILLION)
  • TABLE 301. AFRICA ENDOPROSTHESIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 302. AFRICA ENDOPROSTHESIS MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 303. AFRICA ENDOPROSTHESIS MARKET SIZE, BY DENTAL, 2018-2032 (USD MILLION)
  • TABLE 304. AFRICA ENDOPROSTHESIS MARKET SIZE, BY NEURO, 2018-2032 (USD MILLION)
  • TABLE 305. AFRICA ENDOPROSTHESIS MARKET SIZE, BY ORTHOPEDIC, 2018-2032 (USD MILLION)
  • TABLE 306. AFRICA ENDOPROSTHESIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 307. ASIA-PACIFIC ENDOPROSTHESIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 308. ASIA-PACIFIC ENDOPROSTHESIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 309. ASIA-PACIFIC ENDOPROSTHESIS MARKET SIZE, BY DENTAL, 2018-2032 (USD MILLION)
  • TABLE 310. ASIA-PACIFIC ENDOPROSTHESIS MARKET SIZE, BY HIP, 2018-2032 (USD MILLION)
  • TABLE 311. ASIA-PACIFIC ENDOPROSTHESIS MARKET SIZE, BY KNEE, 2018-2032 (USD MILLION)
  • TABLE 312. ASIA-PACIFIC ENDOPROSTHESIS MARKET SIZE, BY SHOULDER, 2018-2032 (USD MILLION)
  • TABLE 313. ASIA-PACIFIC ENDOPROSTHESIS MARKET SIZE, BY SPINE, 2018-2032 (USD MILLION)
  • TABLE 314. ASIA-PACIFIC ENDOPROSTHESIS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 315. ASIA-PACIFIC ENDOPROSTHESIS MARKET SIZE, BY COBALT-CHROME, 2018-2032 (USD MILLION)
  • TABLE 316. ASIA-PACIFIC ENDOPROSTHESIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 317. ASIA-PACIFIC ENDOPROSTHESIS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 318. ASIA-PACIFIC ENDOPROSTHESIS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 319. ASIA-PACIFIC ENDOPROSTHESIS MARKET SIZE, BY ORTHOPEDIC CLINICS, 2018-2032 (USD MILLION)
  • TABLE 320. ASIA-PACIFIC ENDOPROSTHESIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 321. ASIA-PACIFIC ENDOPROSTHESIS MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 322. ASIA-PACIFIC ENDOPROSTHESIS MARKET SIZE, BY DENTAL, 2018-2032 (USD MILLION)
  • TABLE 323. ASIA-PACIFIC ENDOPROSTHESIS MARKET SIZE, BY NEURO, 2018-2032 (USD MILLION)
  • TABLE 324. ASIA-PACIFIC ENDOPROSTHESIS MARKET SIZE, BY ORTHOPEDIC, 2018-2032 (USD MILLION)
  • TABLE 325. ASIA-PACIFIC ENDOPROSTHESIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 326. GLOBAL ENDOPROSTHESIS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 327. ASEAN ENDOPROSTHESIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 328. ASEAN ENDOPROSTHESIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 329. ASEAN ENDOPROSTHESIS MARKET SIZE, BY DENTAL, 2018-2032 (USD MILLION)
  • TABLE 330. ASEAN ENDOPROSTHESIS MARKET SIZE, BY HIP, 2018-2032 (USD MILLION)
  • TABLE 331. ASEAN ENDOPROSTHESIS MARKET SIZE, BY KNEE, 2018-2032 (USD MILLION)
  • TABLE 332. ASEAN ENDOPROSTHESIS MARKET SIZE, BY SHOULDER, 2018-2032 (USD MILLION)
  • TABLE 333. ASEAN ENDOPROSTHESIS MARKET SIZE, BY SPINE, 2018-2032 (USD MILLION)
  • TABLE 334. ASEAN ENDOPROSTHESIS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 335. ASEAN ENDOPROSTHESIS MARKET SIZE, BY COBALT-CHROME, 2018-2032 (USD MILLION)
  • TABLE 336. ASEAN ENDOPROSTHESIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 337. ASEAN ENDOPROSTHESIS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 338. ASEAN ENDOPROSTHESIS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 339. ASEAN ENDOPROSTHESIS MARKET SIZE, BY ORTHOPEDIC CLINICS, 2018-2032 (USD MILLION)
  • TABLE 340. ASEAN ENDOPROSTHESIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 341. ASEAN ENDOPROSTHESIS MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 342. ASEAN ENDOPROSTHESIS MARKET SIZE, BY DENTAL, 2018-2032 (USD MILLION)
  • TABLE 343. ASEAN ENDOPROSTHESIS MARKET SIZE, BY NEURO, 2018-2032 (USD MILLION)
  • TABLE 344. ASEAN ENDOPROSTHESIS MARKET SIZE, BY ORTHOPEDIC, 2018-2032 (USD MILLION)
  • TABLE 345. ASEAN ENDOPROSTHESIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 346. GCC ENDOPROSTHESIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 347. GCC ENDOPROSTHESIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 348. GCC ENDOPROSTHESIS MARKET SIZE, BY DENTAL, 2018-2032 (USD MILLION)
  • TABLE 349. GCC ENDOPROSTHESIS MARKET SIZE, BY HIP, 2018-2032 (USD MILLION)
  • TABLE 350. GCC ENDOPROSTHESIS MARKET SIZE, BY KNEE, 2018-2032 (USD MILLION)
  • TABLE 351. GCC ENDOPROSTHESIS MARKET SIZE, BY SHOULDER, 2018-2032 (USD MILLION)
  • TABLE 352. GCC ENDOPROSTHESIS MARKET SIZE, BY SPINE, 2018-2032 (USD MILLION)
  • TABLE 353. GCC ENDOPROSTHESIS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 354. GCC ENDOPROSTHESIS MARKET SIZE, BY COBALT-CHROME, 2018-2032 (USD MILLION)
  • TABLE 355. GCC ENDOPROSTHESIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 356. GCC ENDOPROSTHESIS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 357. GCC ENDOPROSTHESIS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 358. GCC ENDOPROSTHESIS MARKET SIZE, BY ORTHOPEDIC CLINICS, 2018-2032 (USD MILLION)
  • TABLE 359. GCC ENDOPROSTHESIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)

TA